Mikael Palner

Mikael Palner is an Associate Professor in the Department of Clinical Research at Odense University Hospital, with affiliations at Karolinska Institute (KI) and Rigshospitalet since November 2016. He specializes in translational pharmacology, neurobiology, and nuclear medicine with particular expertise in preclinical PK/PD, in vivo imaging, and behavioral pharmacology.

• Primary Affiliation: Department of Clinical Research, Odense University Hospital
• Additional Affiliation: Rigshospitalet (since 2016)
• Academic Affiliation: Karolinska Institute

His research focuses on neuropsychiatric diseases including anxiety, obsessive-compulsive disorder, and post-traumatic stress syndrome, with special interest in psychedelic drug action and novel treatment options. He has developed significant expertise in:

• Translational pharmacology
• In vitro kinetics
• Animal models
• Neuroreceptor imaging
• Stress resilience mechanisms
• Metabolic connectivity mapping

The 15 most recent publications reveal a strong focus on psychedelic drug mechanisms, particularly psilocybin and DMT, with emphasis on:

• 5-HT2A receptor dynamics
• Neuroplasticity modulation
• Stress response systems
• Cognitive flexibility changes
• Metabolic pathway interactions
• Novel imaging probe development

Mikael Palner maintains active engagement in public outreach and scientific communication, appearing in documentaries and serving as a media expert on psychedelic research and neuropsychiatric treatment options.